ENU mutagenesis, a way forward to understand gene function.

Arguably, the main challenge for contemporary genetics is to understand the function of every gene in a mammalian genome. The mouse has emerged as a model for this task because its genome can be manipulated in a number of ways to study gene function or mimic disease states. Two complementary genetic approaches can be used to generate mouse models. A reverse genetics or gene-driven approach (gene to phenotype) starts from a known gene and manipulates the genome to create genetically modified mice, such as knockouts. Alternatively, a forward genetics or phenotype-driven approach (phenotype to gene) involves screening mice for mutant phenotypes without previous knowledge of the genetic basis of the mutation. N-ethyl-N-nitrosourea (ENU) mutagenesis has been widely used for both approaches to generate mouse mutants. Here we review progress in ENU mutagenesis screening, with an emphasis on creating mouse models for human disorders.

[1]  M. Lyon,et al.  Mutation rates at a new set of specific loci in the mouse. , 1966, Genetical research.

[2]  T. Hudson,et al.  A genome-wide association study identifies novel risk loci for type 2 diabetes , 2007, Nature.

[3]  Gerhard K. H. Przemeck,et al.  A Genetic Screen for Modifiers of the Delta1-Dependent Notch Signaling Function in the Mouse , 2007, Genetics.

[4]  Steve D. M. Brown,et al.  A mutation in the F-box gene, Fbxo11, causes otitis media in the Jeff mouse. , 2006, Human molecular genetics.

[5]  Klaus Schughart,et al.  Genome-wide, large-scale production of mutant mice by ENU mutagenesis , 2000, Nature Genetics.

[6]  R. Cox,et al.  A new mouse model of type 2 diabetes, produced by N-ethyl-nitrosourea mutagenesis, is the result of a missense mutation in the glucokinase gene. , 2004, Diabetes.

[7]  F. Ashcroft,et al.  Nicotinamide nucleotide transhydrogenase: a key role in insulin secretion. , 2006, Cell metabolism.

[8]  Hiroshi Masuya,et al.  A series of maturity onset diabetes of the young, type 2 (MODY2) mouse models generated by a large-scale ENU mutagenesis program. , 2004, Human molecular genetics.

[9]  W. Frankel,et al.  Severe epilepsy resulting from genetic interaction between Scn2a and Kcnq2. , 2006, Human molecular genetics.

[10]  Judy H. Cho,et al.  A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene , 2006, Science.

[11]  K. Anderson,et al.  Rab23 is an essential negative regulator of the mouse Sonic hedgehog signalling pathway , 2001, Nature.

[12]  S. Neubauer,et al.  Identification of cardiac malformations in mice lacking Ptdsr using a novel high-throughput magnetic resonance imaging technique , 2004, BMC Developmental Biology.

[13]  T. Clark,et al.  Estimating the number of coding mutations in genotypic and phenotypic driven N-ethyl-N-nitrosourea (ENU) screens: revisited , 2006, Mammalian Genome.

[14]  C. G. Wright,et al.  Characterization of a new allele of Ames waltzer generated by ENU mutagenesis , 2005, Hearing Research.

[15]  P M Nolan,et al.  Screening for novel ENU‐induced rhythm, entrainment and activity mutants , 2004, Genes, brain, and behavior.

[16]  Kieran Clarke,et al.  µMRI–HREM pipeline for high‐throughput, high‐resolution phenotyping of murine embryos , 2007, Journal of anatomy.

[17]  U. Heinzmann,et al.  A missense mutation in the WD40 domain of murine Lyst is linked to severe progressive Purkinje cell degeneration , 2006, Acta Neuropathologica.

[18]  R. Cox,et al.  ENU mutagenesis in the mouse: application to human genetic disease. , 2002, Briefings in functional genomics & proteomics.

[19]  B. Libby,et al.  Mouse mutants from chemically mutagenized embryonic stem cells , 2000, Nature Genetics.

[20]  J. Bielas,et al.  Proliferation is necessary for both repair and mutation in transgenic mouse cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Justice,et al.  The mutagenic action of N-ethyl-N-nitrosourea in the mouse , 2000, Mammalian Genome.

[22]  P. Hunsicker,et al.  Comparison of the genetic effects of equimolar doses of ENU and MNU: while the chemicals differ dramatically in their mutagenicity in stem-cell spermatogonia, both elicit very high mutation rates in differentiating spermatogonia. , 2007, Mutation research.

[23]  P. Selby,et al.  A strategy for fine-structure functional analysis of a 6- to 11-centimorgan region of mouse chromosome 7 by high-efficiency mutagenesis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Steve D. M. Brown,et al.  Rodent models of genetic disease. , 2003, Current opinion in genetics & development.

[25]  H. Fuchs,et al.  Screening for dysmorphological abnormalities—a powerful tool to isolate new mouse mutants , 2000, Mammalian Genome.

[26]  J. O’Neill,et al.  DNA damage, DNA repair, cell proliferation, and DNA replication: how do gene mutations result? , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  H. Himmelbauer,et al.  Mouse splice mutant generation from ENU-treated ES cells--a gene-driven approach. , 2005, Genomics.

[28]  Steve D. M. Brown,et al.  Novel ENU-induced eye mutations in the mouse: models for human eye disease. , 2002, Human molecular genetics.

[29]  John G. Sled,et al.  Behavioral Phenotypes of Disc1 Missense Mutations in Mice , 2007, Neuron.

[30]  Steve D. M. Brown,et al.  The Deaf Mouse Mutant Jeff (Jf) is a Single Gene Model of Otitis Media , 2003, Journal of the Association for Research in Otolaryngology.

[31]  C. Goodnow,et al.  Illuminating autoimmune regulators through controlled variation of the mouse genome sequence. , 2004, Immunity.

[32]  Werner Müller,et al.  Introducing the German Mouse Clinic: open access platform for standardized phenotyping , 2005, Nature Methods.

[33]  Steve D. M. Brown,et al.  Dissecting the genetic complexity of human 6p deletion syndromes by using a region-specific, phenotype-driven mouse screen. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[34]  H. Masuya,et al.  Molecular characterization of ENU mouse mutagenesis and archives. , 2005, Biochemical and biophysical research communications.

[35]  M. Justice,et al.  Efficient generation and mapping of recessive developmental mutations using ENU mutagenesis , 2002, Nature Genetics.

[36]  Kathryn E. Hentges,et al.  Checks and balancers: balancer chromosomes to facilitate genome annotation. , 2004, Trends in genetics : TIG.

[37]  M. Jarvelin,et al.  A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2007, Science.

[38]  L. Greensmith,et al.  A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice , 2005, The Journal of cell biology.

[39]  B. Beutler,et al.  Unraveling innate immunity using large scale N-ethyl-N-nitrosourea mutagenesis. , 2005, Tissue antigens.

[40]  S. Wells,et al.  Spectrum of ENU‐induced mutations in phenotype‐driven and gene‐driven screens in the mouse , 2007, Environmental and molecular mutagenesis.

[41]  Judy H Cho,et al.  Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis , 2007, Nature Genetics.

[42]  Steve D. M. Brown,et al.  The European dimension for the mouse genome mutagenesis program , 2004 .

[43]  M. Mayhaus,et al.  Efficient and fast targeted production of murine models based on ENU mutagenesis , 2005, Mammalian Genome.

[44]  K. Steel,et al.  Multiple mutations in mouse Chd7 provide models for CHARGE syndrome. , 2005, Human molecular genetics.

[45]  T. Skopek,et al.  Toxicity, mutagenicity, and mutational spectra of N-ethyl-N-nitrosourea in human cell lines with different DNA repair phenotypes. , 1991, Cancer research.

[46]  E. Rinchik Chemical mutagenesis and fine-structure functional analysis of the mouse genome. , 1991, Trends in genetics : TIG.

[47]  B. Beutler,et al.  Analysis of the MCMV resistome by ENU mutagenesis , 2006, Mammalian Genome.

[48]  M. Pagano,et al.  The After-Hours Mutant Reveals a Role for Fbxl3 in Determining Mammalian Circadian Period , 2007, Science.

[49]  Bin Liu,et al.  Functional genetic analysis of mouse chromosome 11 , 2003, Nature.

[50]  W. Frankel,et al.  Mutation Rate and Predicted Phenotypic Target Sizes in Ethylnitrosourea-Treated Mice , 2004, Genetics.

[51]  Steve D. M. Brown,et al.  Dynein mutations impair autophagic clearance of aggregate-prone proteins , 2005, Nature Genetics.

[52]  Steve D. M. Brown,et al.  A gene-driven approach to the identification of ENU mutants in the mouse , 2002, Nature Genetics.

[53]  Kevin Eggan,et al.  Non–cell autonomous effect of glia on motor neurons in an embryonic stem cell–based ALS model , 2007, Nature Neuroscience.

[54]  D. P. King,et al.  Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior. , 1994, Science.

[55]  Minoru Tanaka,et al.  Positional Cloning of the Mouse Circadian Clock Gene , 1997, Cell.

[56]  B. Beutler,et al.  Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis , 2007, The Journal of Experimental Medicine.

[57]  Simon C. Potter,et al.  Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants , 2007, Nature Genetics.

[58]  T. Schöneberg,et al.  N-ethyl-N-nitrosourea-based generation of mouse models for mutant G protein-coupled receptors. , 2006, Physiological genomics.

[59]  L. Tarantino,et al.  A Forward Genetics Screen in Mice Identifies Recessive Deafness Traits and Reveals That Pejvakin Is Essential for Outer Hair Cell Function , 2007, The Journal of Neuroscience.

[60]  M. Traka,et al.  Nmf11 is a novel ENU-induced mutation in the mouse glycine receptor alpha 1 subunit , 2006, Mammalian Genome.

[61]  M. Kas,et al.  Dissecting complex behaviours in the post-genomic era , 2004, Trends in Neurosciences.

[62]  Yasushi Hiraoka,et al.  Mutations in Dynein Link Motor Neuron Degeneration to Defects in Retrograde Transport , 2003, Science.

[63]  Steve D. M. Brown,et al.  A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse , 2000, Nature Genetics.

[64]  Steve D. M. Brown,et al.  Identification of two new Pmp22 mouse mutants using large-scale mutagenesis and a novel rapid mapping strategy , 2000 .

[65]  N. Claij,et al.  DNA mismatch repair deficiency stimulates N-ethyl-N-nitrosourea-induced mutagenesis and lymphomagenesis. , 2003, Cancer research.

[66]  V. Chapman,et al.  Effects of ENU dosage on mouse strains , 2000, Mammalian Genome.

[67]  H. Masuya,et al.  A novel dominant-negative mutation in Gdf5 generated by ENU mutagenesis impairs joint formation and causes osteoarthritis in mice. , 2007, Human molecular genetics.

[68]  M. Justice,et al.  Optimal N‐Ethyl‐N‐nitrosourea (ENU) doses for inbred mouse strains , 2000, Genesis.

[69]  D. Reed,et al.  Forty mouse strain survey of body composition , 2007, Physiology & Behavior.

[70]  P. Visscher,et al.  Marker-assisted introgression in backcross breeding programs. , 1996, Genetics.

[71]  Jason P. DeBruyne,et al.  A Clock Shock: Mouse CLOCK Is Not Required for Circadian Oscillator Function , 2006, Neuron.

[72]  W L Russell,et al.  Dose-repetition increases the mutagenic effectiveness of N-ethyl-N-nitrosourea in mouse spermatogonia. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[73]  Richard J. Mural,et al.  Genome-wide single-nucleotide polymorphism analysis defines haplotype patterns in mouse , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[74]  C. Goodnow,et al.  Connecting mammalian genome with phenome by ENU mouse mutagenesis: gene combinations specifying the immune system. , 2005, Annual review of genetics.

[75]  Terry Magnuson,et al.  An allelic series of mutations in Smad2 and Smad4 identified in a genotype-based screen of N-ethyl-N- nitrosourea-mutagenized mouse embryonic stem cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[76]  John M. Hancock,et al.  Understanding Mammalian Genetic Systems: The Challenge of Phenotyping in the Mouse , 2006, PLoS genetics.

[77]  M. J. Justice,et al.  Mouse ENU mutagenesis. , 1999, Human molecular genetics.

[78]  R. Copley,et al.  A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity , 2005, Nature.

[79]  Steve D. M. Brown,et al.  A Mutation in Af4 Is Predicted to Cause Cerebellar Ataxia and Cataracts in the Robotic Mouse , 2003, The Journal of Neuroscience.

[80]  M. Bucan,et al.  Mutations in Rab3a alter circadian period and homeostatic response to sleep loss in the mouse , 2002, Nature Genetics.

[81]  Steve D. M. Brown,et al.  A gene-driven ENU-based approach to generating an allelic series in any gene , 2004, Mammalian Genome.

[82]  H. Fuchs,et al.  Autoimmunity and inflammation due to a gain-of-function mutation in phospholipase C gamma 2 that specifically increases external Ca2+ entry. , 2005, Immunity.

[83]  S. Rastan,et al.  Novel Mouse Model of Autosomal Semidominant Adult Hypophosphatasia Has a Splice Site Mutation in the Tissue Nonspecific Alkaline Phosphatase Gene Akp2 , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[84]  T. Skopek,et al.  Mutational spectrum at the Hprt locus in splenic T cells of B6C3F1 mice exposed to N-ethyl-N-nitrosourea. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[85]  D. Hilton,et al.  The art and design of genetic screens: mouse , 2005, Nature Reviews Genetics.

[86]  M. Justice,et al.  A new ENU-induced allele of mouse quaking causes severe CNS dysmyelination , 2005, Mammalian Genome.

[87]  Steve D. M. Brown,et al.  Novel phenotypes identified by plasma biochemical screening in the mouse , 2002, Mammalian Genome.

[88]  J. Favor The mutagenic activity of ethylnitrosourea at low doses in spermatogonia of the mouse as assessed by the specific-locus test. , 1998, Mutation research.

[89]  Steve D. M. Brown,et al.  Mutation at the Evi1 Locus in Junbo Mice Causes Susceptibility to Otitis Media , 2006, PLoS genetics.

[90]  T. Magnuson,et al.  Genotype-based screen for ENU-induced mutations in mouse embryonic stem cells , 2000, Nature Genetics.

[91]  Steve D. M. Brown,et al.  Association of the FBXO11 gene with chronic otitis media with effusion and recurrent otitis media: the Minnesota COME/ROM Family Study. , 2006, Archives of otolaryngology--head & neck surgery.

[92]  E. Fisher,et al.  Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment , 1997, Mammalian Genome.

[93]  J. Roder,et al.  Forward genetic screen of mouse reveals dominant missense mutation in the P/Q‐type voltage‐dependent calcium channel, CACNA1A , 2007, Genes, brain, and behavior.

[94]  R. A. Bailey,et al.  Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes , 2007, Nature Genetics.

[95]  Y. Gondo,et al.  Mutational pattern and frequency of induced nucleotide changes in mouse ENU mutagenesis , 2007, BMC Molecular Biology.

[96]  Steve D. M. Brown,et al.  Mutations in α-Tubulin Cause Abnormal Neuronal Migration in Mice and Lissencephaly in Humans , 2007, Cell.

[97]  M. MacDonald,et al.  Huntington's disease: seeing the pathogenic process through a genetic lens. , 2006, Trends in biochemical sciences.

[98]  C. Goodnow,et al.  Genome-wide ENU mutagenesis to reveal immune regulators. , 2001, Immunity.

[99]  D. Carpenter,et al.  Effect of dose fractionation on the ethylnitrosourea induction of specific-locus mutations in mouse spermatogonia. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[100]  Joseph H. Nadeau,et al.  Implementing Large-Scale ENU Mutagenesis Screens in North America , 2004, Genetica.

[101]  P. Hunsicker,et al.  Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[102]  W. Alexander,et al.  Suppressor screen in Mpl-/- mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[103]  S. Cross,et al.  Genotype-phenotype correlation of mouse pde6b mutations. , 2005, Investigative ophthalmology & visual science.

[104]  R. Balling ENU mutagenesis: analyzing gene function in mice. , 2001, Annual review of genomics and human genetics.

[105]  P Chambon,et al.  EMPReSS: standardized phenotype screens for functional annotation of the mouse genome , 2005, Nature Genetics.

[106]  R. E. Olszewski,et al.  Efficient gene-driven germ-line point mutagenesis of C57BL/6J mice , 2005, BMC Genomics.

[107]  T. Shibuya,et al.  The induction of recessive mutations in mouse primordial germ cells with N-ethyl-N-nitrosourea. , 1993, Mutation research.

[108]  W. Frankel,et al.  Three ENU-induced neurological mutations in the pore loopof sodium channel Scn8a (Nav1.6) and a genetically linkedretinal mutation, rd13 , 2004, Mammalian Genome.

[109]  D. Rubinsztein Lessons from animal models of Huntington's disease. , 2002, Trends in genetics : TIG.